These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA. Ibrahim SA; Fayed EA; Rizk HF; Desouky SE; Ragab A Bioorg Chem; 2021 Nov; 116():105339. PubMed ID: 34530234 [TBL] [Abstract][Full Text] [Related]
3. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity. Kassab AE; Gedawy EM Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker. Zhang GY; Zhang Z; Li K; Liu J; Li B; Jin Z; Liu YH; Tang YZ Bioorg Chem; 2020 Dec; 105():104398. PubMed ID: 33137559 [TBL] [Abstract][Full Text] [Related]
5. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity. Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Abdel-Wahab BF; Abdel-Aziz HA; Ahmed EM Eur J Med Chem; 2009 Jun; 44(6):2632-5. PubMed ID: 18995932 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of antimicrobial and anticancer activities of 3-phenyl-1-phenylsulfonyl pyrazoles containing an aminoguanidine moiety. Huang Y; Hu H; Yan R; Lin L; Song M; Yao X Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000165. PubMed ID: 33047391 [TBL] [Abstract][Full Text] [Related]
8. Pyrazolidine-3,5-diones and 5-hydroxy-1H-pyrazol-3(2H)-ones, inhibitors of UDP-N-acetylenolpyruvyl glucosamine reductase. Gilbert AM; Failli A; Shumsky J; Yang Y; Severin A; Singh G; Hu W; Keeney D; Petersen PJ; Katz AH J Med Chem; 2006 Oct; 49(20):6027-36. PubMed ID: 17004716 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-staphylococcal activity of new 4-diazopyrazole derivatives. Raimondi MV; Maggio B; Raffa D; Plescia F; Cascioferro S; Cancemi G; Schillaci D; Cusimano MG; Vitale M; Daidone G Eur J Med Chem; 2012 Dec; 58():64-71. PubMed ID: 23088933 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel 1,2-diarylpyrazolidin-3-one-based compounds and their evaluation as broad spectrum antibacterial agents. Mokbel SA; Fathalla RK; El-Sharkawy LY; Abadi AH; Engel M; Abdel-Halim M Bioorg Chem; 2020 Jun; 99():103759. PubMed ID: 32220665 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, antimicrobial, anti-cancer and in silico studies of new urea derivatives. Sroor FM; Othman AM; Tantawy MA; Mahrous KF; El-Naggar ME Bioorg Chem; 2021 Jul; 112():104953. PubMed ID: 33964581 [TBL] [Abstract][Full Text] [Related]
12. Optimization of activity localization of quinoline derivatives: Design, synthesis, and dual evaluation of biological activity for potential antitumor and antibacterial agents. Jin G; Li Z; Xiao F; Qi X; Sun X Bioorg Chem; 2020 Jun; 99():103837. PubMed ID: 32299019 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, in-vitro and in-silico study of novel thiazoles as potent antibacterial agents and MurB inhibitors. Sanad SMH; Ahmed AAM; Mekky AEM Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900309. PubMed ID: 31967349 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3,5-Bis(trifluoromethyl)phenyl-Substituted Pyrazole Derivatives as Potent Growth Inhibitors of Drug-Resistant Bacteria. Alkhaibari IS; Kc HR; Roy S; Abu-Gazleh MK; Gilmore DF; Alam MA Molecules; 2021 Aug; 26(16):. PubMed ID: 34443670 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial and cytotoxic activities of new N-3 substituted thiazolidine-2,4-dione derivatives bearing the pyrazole moiety. Desai NC; Satodiya HM; Kotadiya GM; Vaghani HV Arch Pharm (Weinheim); 2014 Jul; 347(7):523-32. PubMed ID: 24729458 [TBL] [Abstract][Full Text] [Related]
16. 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents. Hansa RK; Khan MMK; Frangie MM; Gilmore DF; Shelton RS; Savenka AV; Basnakian AG; Shuttleworth SL; Smeltzer MS; Alam MA Eur J Med Chem; 2021 Jul; 219():113402. PubMed ID: 33845234 [TBL] [Abstract][Full Text] [Related]
17. 1-Substituted carbamoyl and thiocarbamoyl-4,5-dihydro-1H-pyrazoles as possible cytotoxic and antimicrobial agents. Khan KA; Faidallah HM J Enzyme Inhib Med Chem; 2016 Aug; 31(4):619-27. PubMed ID: 26114308 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study. El-Khouly OA; Henen MA; El-Sayed MA; Shabaan MI; El-Messery SM Bioorg Med Chem; 2021 Feb; 31():115976. PubMed ID: 33388654 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives. El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190 [TBL] [Abstract][Full Text] [Related]
20. In silico identification, synthesis and biological evaluation of novel tetrazole inhibitors of MurB. Hrast M; Jukič M; Patin D; Tod J; Dowson CG; Roper DI; Barreteau H; Gobec S Chem Biol Drug Des; 2018 Jun; 91(6):1101-1112. PubMed ID: 29363274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]